Search

everythinglearnresearchcommunity

for

Search:↓

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Flutamide reduces hair growth better but has more side effects.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Quercetin may help with PCOS symptoms, but more research is needed.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Finasteride shows promise for female hair loss, but more research needed.

Finasteride effectively treats male hair loss, improving growth and density.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.